6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
ID: 36C77026Q0052Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/workspace/contract/opp/84cc718b3d6c43078b00fc473605d387/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    (913) 946-1975
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77026Q0052_1.docx
    This document is a Request for Quotations (RFQ) from the Department of Veterans Affairs (VA) for pharmaceutical products, specifically Jasiel (J0040) 28-day tablets and Drospirenone 4mg (D1217). The solicitation, number 36C77026Q0052, is a 100% small business set-aside with a NAICS code of 325412 and a size standard of 1300 employees. The VA is seeking offers for these two pharmaceutical line items for the VA CMOP Ladson (Charleston) facility. Key requirements for offerors include providing a signed SF 1449 cover page, a pricing schedule in Excel format, a valid and unexpired state wholesale distributor license, and a BAA Certificate if quoting non-domestic products. Deliveries will be staggered over a six-month period, with specific instructions for shipping, tracking, and invoicing. All pharmaceutical products must comply with bar coding standards (GS1-128 or HIBCC), have a therapeutic equivalence code of “A” from the FDA (unless otherwise specified), and adhere to the Drug Supply Chain Security Act (DSCSA) for prescription pharmaceuticals. Offers will be evaluated based on past performance and price, with the government reserving the right to award without discussions.
    36C77026Q0052.docx
    The Department of Veterans Affairs, Network Contracting Office 15, CMOP Division, intends to procure two pharmaceuticals: JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217). This requirement, identified by Solicitation Number 36C77026Q0052, is a Small Business set-aside with Product Codes 6505 (Drugs and Biologicals) and NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). The pharmaceuticals are for delivery to the CMOP facility in Ladson, SC, with an estimated issue date of December 22, 2025, and an estimated response due date of January 5, 2026. Delivery will be staggered over a six-month period. Offerors must submit a quotation via email to Kelley Cunningham, including a signed SF1449, a price schedule in Excel format, a valid state wholesale distributor license verifying compliance with the Drug Supply Chain Security Act (DSCSA), and a Buy American Act (BAA) Certificate detailing the place of manufacturing. All responsible sources are encouraged to submit a timely quotation.
    S02_JnA_Q0052.pdf
    The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 15 – Consolidated Mail Outpatient Pharmacy (CMOP) Division, is seeking to procure the brand-name pharmaceutical JASMIEL (J0040) 28-DAY TABLET for the Ladson (Charleston) CMOP. This justification for a brand-name award, under Simplified Acquisition Procedures (SAP) and below the Simplified Acquisition Threshold (SAT), is necessary because the product has been prescribed by VA physicians, and no National Drug Code (NDC) substitutions are permitted. Market research confirmed that the pharmaceutical is not available through typical contract vehicles or supply chains, necessitating an open market procurement. Despite extensive searches, including the SBA’s Dynamic Small Business Search, NIH DailyMed, and a Request for Information (RFI), no domestic manufacturers capable of supplying the pharmaceutical were identified. While authorized small business distributors exist, a socioeconomic-specific set-aside is not feasible without a waiver for the Non-Manufacturer Rule (NMR), which does not apply to total small business set-asides below the SAT. The contracting officer approved the purchase in accordance with FAR 13.106-1(b).
    S02_Pricing Schedule_Q0052.xlsx
    The CMOP - Ladson (Charleston) RFQ: 36C77026Q0052 is a solicitation for pharmaceutical supplies, specifically JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), with delivery staggered evenly over a six-month period, beginning ten days after receipt of order. Vendors must submit a signed SF1449, a completed quote spreadsheet, a valid State Wholesale Distributor License, and a Buy American Act (BAA) Certificate by January 5, 2026, at 3:00 PM CT. Quotes should be emailed to Kelley.Cunningham@va.gov. Important requirements include noting any alternate NDCs with adjusted quantities and providing expiration dates (which must be at least one year from delivery) in the "Vendor Comments" section of the quote spreadsheet.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77026Q0060
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of various dosages of Duloxetine HCl capsules, intended for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. This presolicitation notice (36C77026Q0060) outlines a requirement for monthly deliveries over a three-month period, with specific quantities and packaging details for each item, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to strict delivery and packaging standards. Interested vendors must submit their quotes, including a signed SF1449, a price schedule in Excel format, and a state wholesale distributor license, by January 2, 2026, with an estimated award date of January 23, 2026. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Tucson CMOP COAL TAR 2% SHAMPOO 240ML AND MOISTURIZING LOTION
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the National CMOP Office, is seeking to procure Coal Tar 2% Shampoo and Moisturizing Lotion for its Tucson facility through a presolicitation notice (RFQ: 36C77026Q0057). This procurement is set aside for small businesses and falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, highlighting the importance of these products in treating various dermatological conditions. Interested vendors must be registered in SAM.gov and comply with the Drug Supply Chain Security Act, providing necessary documentation including a signed SF1449 and pricing schedule, with responses due by December 29, 2025, at 4 PM CST. For further inquiries, vendors can contact Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.